A previous study found that increased IL-3 expression by CD4+ T cells is associated with relapses in MS patients, encephalitogenic CD4+ T cells are the primary source of IL-3 in EAE, and the administration of IL-3 to mice with EAE exacerbates disease (16, 25). The gene discussed is IL3; the disease is myeloid sarcoma.